These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16688383)

  • 21. Stratum corneum cytokines and skin irritation response to sodium lauryl sulfate.
    De Jongh CM; Verberk MM; Withagen CE; Jacobs JJ; Rustemeyer T; Kezic S
    Contact Dermatitis; 2006 Jun; 54(6):325-33. PubMed ID: 16787454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo evaluation of unbound water accumulation in stratum corneum. The influence of acute skin irritation induced by sodium laurylsulfate.
    van Neste D
    Dermatologica; 1990; 181(3):197-201. PubMed ID: 2269378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential modulation of CXCR4 and CD40 protein levels by skin sensitizers and irritants in the FSDC cell line.
    Neves BM; Cruz MT; Francisco V; Gonçalo M; Figueiredo A; Duarte CB; Lopes MC
    Toxicol Lett; 2008 Feb; 177(1):74-82. PubMed ID: 18281165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An alternative test battery in detecting ocular irritancy of agrochemicals.
    Tavaszi J; Budai P; Pálovics A; Kismányoki A
    Commun Agric Appl Biol Sci; 2008; 73(4):891-5. PubMed ID: 19226840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of human skin recombinants as an in vitro model for testing the irritation potential of cutaneous irritants.
    Ponec M; Kempenaar J
    Skin Pharmacol; 1995; 8(1-2):49-59. PubMed ID: 7786525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of leukaemia inhibitory factor and interleukin-1alpha intracellular content in a human keratinocyte cell line after exposure to cosmetic fragrances and sodium dodecyl sulphate.
    Parodi A; Sanguineti R; Catalano M; Penco S; Pronzato MA; Scanarotti C; Bassi AM
    Toxicol Lett; 2010 Feb; 192(2):101-7. PubMed ID: 19878710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amended final report on the safety assessment of glyceryl dilaurate, glyceryl diarachidate, glyceryl dibehenate, glyceryl dierucate, glyceryl dihydroxystearate, glyceryl diisopalmitate, glyceryl diisostearate, glyceryl dilinoleate, glyceryl dimyristate, glyceryl dioleate, glyceryl diricinoleate, glyceryl dipalmitate, glyceryl dipalmitoleate, glyceryl distearate, glyceryl palmitate lactate, glyceryl stearate citrate, glyceryl stearate lactate, and glyceryl stearate succinate.
    Int J Toxicol; 2007; 26 Suppl 3():1-30. PubMed ID: 18273450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The isolated perfused Bovine Udder Skin.
    Pittermann W; Kietzmann M; Jackwerth B
    ALTEX; 1995; 12(4):196-200. PubMed ID: 11178435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The irritant potential of n-propanol (nonanoic acid vehicle) in cumulative skin irritation: a validation study of two different human in vivo test models.
    Clemmensen A; Andersen F; Petersen TK; Kalden H; Melgaard A; Andersen KE
    Skin Res Technol; 2008 Aug; 14(3):277-86. PubMed ID: 19159372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Harmonization of thresholds for primary skin irritation from results of human repeated insult patch tests and laboratory animal skin irritation tests.
    Tardiff RG; Hubner RP; Graves CG
    J Appl Toxicol; 2003; 23(4):279-81. PubMed ID: 12884413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-occlusive topical exposure of human skin in vitro as model for cytotoxicity testing of irritant compounds.
    Lönnqvist S; Briheim K; Kratz G
    Toxicol Mech Methods; 2016 Feb; 26(2):82-7. PubMed ID: 26446981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the skin irritation using a DNA microarray on a reconstructed human epidermal model.
    Niwa M; Nagai K; Oike H; Kobori M
    Biol Pharm Bull; 2009 Feb; 32(2):203-8. PubMed ID: 19182376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the Bovine Udder Skin model to evaluate the tolerability of Mesem cosmetic cream.
    Raak C; Molsberger F; Pittermann W; Bertram M; Robens S; Ostermann T
    Altern Lab Anim; 2017 Sep; 45(4):191-200. PubMed ID: 28994299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The isolated perfused bovine uterus as a model for mucous membrane irritation and inflammation.
    Bäumer W; Mertens A; Braun M; Kietzmann M
    ALTEX; 2002; 19(2):57-63. PubMed ID: 12098010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The isolated perfused bovine udder as a model of dermal eicosanoid release.
    Bäumer W; Kietzmann M
    Altern Lab Anim; 2000; 28(5):643-9. PubMed ID: 11091763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of toxic potential of industrial chemicals using a cultured human bioartificial skin model: production of interleukin 1alpha and hydroxyeicosatetraenoic acids.
    Yang EK; Yoon HH; Lee DH; Park JK
    Skin Pharmacol Appl Skin Physiol; 2000; 13(5):246-57. PubMed ID: 10940814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subclinical, non-erythematous irritation with an open assay model (washing): sodium lauryl sulfate (SLS) versus sodium laureth sulfate (SLES).
    Charbonnier V; Morrison BM; Paye M; Maibach HI
    Food Chem Toxicol; 2001 Mar; 39(3):279-86. PubMed ID: 11278060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shielded corneosurfametry and corneoxenometry: novel bioassays for the assessment of skin barrier products.
    Goffin V; Piérard-Franchimont C; Piérard GE
    Dermatology; 1998; 196(4):434-7. PubMed ID: 9669124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of concentration, exposure duration, and patch occlusivity upon rabbit primary dermal irritation indices.
    Gilman MR; Evans RA; De Salva SJ
    Drug Chem Toxicol; 1978; 1(4):391-400. PubMed ID: 755678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opposing effects of glycerol on the protective function of the horny layer against irritants and on the penetration of hexyl nicotinate.
    Bettinger J; Gloor M; Peter C; Kleesz P; Fluhr J; Gehring W
    Dermatology; 1998; 197(1):18-24. PubMed ID: 9693180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.